Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen
Accession Number
DB10798
Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Toxoid
Description

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.

Synonyms
  • Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
MenactraNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularSanofi Pasteur Inc.2005-01-14Not applicableUs
MenactraNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularRemedy Repack2015-01-032016-03-29Us
MenactraNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL)SolutionIntramuscularSanofi Pasteur Limited2006-10-20Not applicableCanada
Categories
UNII
RE9A0H8OAB
CAS number
Not Available

Pharmacology

Indication
Not Available
Associated Conditions
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910904

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedPreventionMeningococcal Vaccines1
1CompletedPreventionPlasmodium Infections2
1, 2CompletedPreventionMeningococcal Infections / Meningococcal Meningitis1
2CompletedPreventionDiphtheria / Meningococcal Meningitis / Pertussis / Poliomyelitis / Tetanus1
2CompletedPreventionMeningitis / Meningococcal Infections4
2CompletedPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis2
2CompletedPreventionMeningitis / Meningococcal Infections / Neisseria Meningitidis1
2CompletedPreventionMeningitis / Meningococcal sepsis3
2CompletedPreventionMeningococcal Infections2
2CompletedPreventionMeningococcal Meningitis1
2TerminatedPreventionMeningitis / Meningococcal sepsis1
3CompletedPreventionDiphtheria / Meningitis / Neoplasms, Glandular and Epithelial / Tetanus / Whooping Cough1
3CompletedPreventionHuman Papillomavirus Infections1
3CompletedPreventionMeningitis / Meningococcal Disease1
3CompletedPreventionMeningitis / Meningococcal Infections3
3CompletedPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
3CompletedPreventionMeningococcal Infections1
3CompletedPreventionMeningococcal Infections / Neisseria Meningitidis1
3CompletedPreventionMeningococcal Meningitis / Mumps / Rubella / Rubeola / Varicella3
3Not Yet RecruitingPreventionMeningococcal Meningitis1
4Active Not RecruitingPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
4CompletedPreventionDiphtheria / Haemophilus Influenzae Serotype b (Hib) / Meningitis / Meningococcal Infections / Pertussis / Tetanus1
4CompletedPreventionDiphtheria / Meningitis / Meningococcal sepsis / Pertussis / Tetanus1
4CompletedPreventionMeningitis1
4CompletedPreventionMeningitis / Meningococcal Disease1
4CompletedPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
4CompletedTreatmentMeningitis / Meningococcal Infections / Meningococcal Meningitis1
4RecruitingPreventionMeningococcal Disease, Invasive1
Not AvailableCompletedNot AvailableMeningitis / Meningococcal Infections2
Not AvailableCompletedNot AvailableMeningitis / Meningococcal Infections / Meningococcal Meningitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, solutionIntramuscular
SolutionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on December 01, 2015 13:04 / Updated on June 04, 2019 07:15